H.pylori gastric adenocarcinoma pathophysiology

Helicobacter pylori infection Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology Gastritis Peptic ulcer disease Gastric adenocarcinoma MALT lymphoma
Causes
Differentiating Helicobacter pylori infection from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Guideline Recommendation ACG guidelines ESPGHAN and NASPGHAN guidelines
History and Symptoms
Physical Examination
Diagnostic tests Endoscopic tests Nonendoscopic tests
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
H.pylori gastric adenocarcinoma pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of H.pylori gastric adenocarcinoma pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on H.pylori gastric adenocarcinoma pathophysiology
CDC on H.pylori gastric adenocarcinoma pathophysiology
H.pylori gastric adenocarcinoma pathophysiology in the news
Blogs on H.pylori gastric adenocarcinoma pathophysiology
Directions to Hospitals Treating Helicobacter pylori infection
Risk calculators and risk factors for H.pylori gastric adenocarcinoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Pathophysiology

• Gastric cancer is the second leading cause of cancer-related deaths worldwide and H.pylori is the strongest known risk factor for gastric cancer.
• H.pylori is considered as Type I carcinogen.